Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

This study has been completed.
Information provided by:
UCB Pharma Identifier:
First received: February 27, 2008
Last updated: November 14, 2013
Last verified: September 2009